Literature DB >> 10751382

Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation.

K M Murphy1, U N Streips, R B Lock.   

Abstract

Members of the Bcl-2 family of proteins control the cellular commitment to apoptosis, although their role in Fas-induced apoptosis is ill-defined. In this report we demonstrate that activation of the Fas receptor present on a human breast epithelial cell line resulted in a conformational change in the N terminus of the pro-apoptotic protein Bax. This conformational change appeared to occur in the cytosol and precede Bax translocation to the mitochondria. Overexpression of the anti-apoptotic protein Bcl-2 inhibited both the conformational change of Bax as well as its relocalization to the mitochondria. Bcl-2 overexpression did not, however, inhibit Fas-induced cleavage of both procaspase-8 and the pro-apoptotic protein Bid, indicating that Bcl-2 functions downstream of these events. These results suggest that the mechanism by which Bcl-2 inhibits Bax mitochondrial translocation and subsequent amplification of the apoptotic cascade is not by providing a physical barrier to Bax, but rather by inhibiting an upstream event necessary for Bax conformational change.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751382     DOI: 10.1074/jbc.C900590199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate.

Authors:  G W Makin; B M Corfe; G J Griffiths; A Thistlethwaite; J A Hickman; C Dive
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition.

Authors:  Patrizia De Sarno; Svetlana A Shestopal; Taj D King; Anna Zmijewska; Ling Song; Richard S Jope
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

3.  Pharmacological manipulation of Bcl-2 family members to control cell death.

Authors:  Anthony Letai
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Activation of Bak in ultrasound-induced, JNK- and p38-independent apoptosis and its inhibition by Bcl-2.

Authors:  Manabu Kinoshita; Yutaka Eguchi; Kullervo Hynynen
Journal:  Biochem Biophys Res Commun       Date:  2006-12-18       Impact factor: 3.575

5.  Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells.

Authors:  Constantinos Petrovas; Yvonne M Mueller; Ioannis D Dimitriou; Susan R Altork; Anupam Banerjee; Peter Sklar; Karam C Mounzer; John D Altman; Peter D Katsikis
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

6.  Bax is activated during rotavirus-induced apoptosis through the mitochondrial pathway.

Authors:  Sandra Martin-Latil; Laurence Mousson; Arnaud Autret; Florence Colbère-Garapin; Bruno Blondel
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

Review 7.  The rheostat in the membrane: BCL-2 family proteins and apoptosis.

Authors:  N Volkmann; F M Marassi; D D Newmeyer; D Hanein
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

8.  Myxoma virus M11L blocks apoptosis through inhibition of conformational activation of Bax at the mitochondria.

Authors:  Jin Su; Gen Wang; John W Barrett; Timothy S Irvine; Xiujuan Gao; Grant McFadden
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins.

Authors:  Kristi L Norris; Richard J Youle
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

10.  The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways.

Authors:  Mohamed Rahmani; Anh Anderson; Joseph Reza Habibi; Timothy Ryan Crabtree; Mandy Mayo; Hisashi Harada; Andrea Ferreira-Gonzalez; Paul Dent; Steven Grant
Journal:  Blood       Date:  2009-09-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.